Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 20691148)

1.

Mitoxantrone is expelled by the ABCG2 multidrug transporter directly from the plasma membrane.

Homolya L, Orbán TI, Csanády L, Sarkadi B.

Biochim Biophys Acta. 2011 Jan;1808(1):154-63. doi: 10.1016/j.bbamem.2010.07.031. Epub 2010 Aug 4.

2.
4.

Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.

Henriksen U, Gether U, Litman T.

J Cell Sci. 2005 Apr 1;118(Pt 7):1417-26. Epub 2005 Mar 15.

5.
6.

Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.

Henriksen U, Fog JU, Litman T, Gether U.

J Biol Chem. 2005 Nov 4;280(44):36926-34. Epub 2005 Aug 17.

7.
8.

The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.

Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K.

Clin Cancer Res. 2002 Jan;8(1):22-8.

9.

Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance.

Ifergan I, Scheffer GL, Assaraf YG.

Cancer Res. 2005 Dec 1;65(23):10952-8.

10.

Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE.

Clin Cancer Res. 2001 Jan;7(1):145-52.

11.
12.

Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.

Ji N, Yuan J, Liu J, Tian S.

Acta Biochim Biophys Sin (Shanghai). 2010 Dec;42(12):854-62. doi: 10.1093/abbs/gmq097.

PMID:
21106767
13.

Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2.

Litman T, Jensen U, Hansen A, Covitz KM, Zhan Z, Fetsch P, Abati A, Hansen PR, Horn T, Skovsgaard T, Bates SE.

Biochim Biophys Acta. 2002 Sep 20;1565(1):6-16.

PMID:
12225847
14.

Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.

Clark R, Kerr ID, Callaghan R.

Br J Pharmacol. 2006 Nov;149(5):506-15. Epub 2006 Sep 18.

15.

C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.

Bram EE, Ifergan I, Grimberg M, Lemke K, Skladanowski A, Assaraf YG.

Biochem Pharmacol. 2007 Jun 30;74(1):41-53. Epub 2007 Apr 1.

PMID:
17481587
16.

The role of breast cancer resistance protein in acute lymphoblastic leukemia.

Plasschaert SL, van der Kolk DM, de Bont ES, Kamps WA, Morisaki K, Bates SE, Scheffer GL, Scheper RJ, Vellenga E, de Vries EG.

Clin Cancer Res. 2003 Nov 1;9(14):5171-7.

17.

ABCG2 -- a transporter for all seasons.

Sarkadi B, Ozvegy-Laczka C, Német K, Váradi A.

FEBS Lett. 2004 Jun 1;567(1):116-20. Review.

PMID:
15165903
18.

High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells.

Apáti A, Orbán TI, Varga N, Németh A, Schamberger A, Krizsik V, Erdélyi-Belle B, Homolya L, Várady G, Padányi R, Karászi E, Kemna EW, Német K, Sarkadi B.

Biochim Biophys Acta. 2008 Dec;1778(12):2700-9. doi: 10.1016/j.bbamem.2008.08.010. Epub 2008 Aug 20.

19.

The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2.

Shukla S, Robey RW, Bates SE, Ambudkar SV.

Biochemistry. 2006 Jul 25;45(29):8940-51.

PMID:
16846237
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk